Downstream Processing Market Report 2026

The downstream processing market size has grown rapidly in recent years. It will grow from $35.45 billion in 2025 to $40.2 billion in 2026 at a compound annual growth rate (CAGR) of 13.4%. The growth in the historic period can be attributed to biologics market growth, monoclonal antibody production, biopharmaceutical investment, traditional batch processing dominance, regulatory quality standards.

The downstream processing market size is expected to see rapid growth in the next few years. It will grow to $66.59 billion in 2030 at a compound annual growth rate (CAGR) of 13.5%. The growth in the forecast period can be attributed to biosimilar production expansion, vaccine manufacturing growth, automation in bioprocessing, cost-efficient purification demand, cdmo capacity expansion. Major trends in the forecast period include rising demand for biologic drug purification, increased adoption of continuous processing, growing use of single-use technologies, expansion of chromatography-based purification, focus on process yield optimization.

The increasing healthcare expenditure is expected to drive the growth of the downstream processing market in the coming years. Healthcare expenditure encompasses all spending on health services, family planning, nutrition programs, and emergency health aid. Higher expenditure boosts the demand for downstream processing, which involves the extraction of a drug substance (DS) from natural sources, such as bacterial or animal cells, followed by its purification. For example, in May 2024, according to the Office of National Statistics, a UK-based government agency, total healthcare expenditure rose by 5.6% in nominal terms between 2022 and 2023, compared with a 0.9% increase in 2022. Therefore, rising healthcare expenditure is driving the growth of the downstream processing market.

Companies in the downstream processing market are focusing on developing innovative solutions such as flow cells to improve process monitoring, enhance operational efficiency, and strengthen their competitive position. A flow cell is a specialized device that allows continuous passage of liquid samples, enabling real-time observation, analysis, and control of bioprocess conditions during downstream operations. For instance, in October 2023, SCHOTT AG, a Germany-based technology group specializing in specialty glass and glass-ceramics, launched ViewCell, a flow cell designed to support safe and continuous process control in biopharmaceutical manufacturing. ViewCell provides enhanced flexibility for bioprocess monitoring, allowing downstream processes to operate more efficiently by enabling precise, real-time control of critical parameters.

In January 2023, Astea Bio Separations, a UK-based provider of bioseparation and purification technologies, acquired Delta Precision Ltd. for an undisclosed amount. Through this acquisition, Astea Bio Separations aims to expand and strengthen its portfolio of bioprocessing resins, reusable columns, and prepacked single-use columns by integrating Delta Precision’s high-performance chromatography column technologies for biomanufacturing. Delta Precision Ltd. is a UK-based manufacturer of advanced chromatography columns used in protein purification, vaccine production, and drug development.

Major companies operating in the downstream processing market are Sartorius AG, General Electric Company, Merck KGaA, Thermo Fisher Scientific Inc., Danaher Corporation, Repligen Corporation, Lonza Group Ltd., Eppendorf AG, Corning Corporation, Ashai Kasei Corporation, Finesse Solutions Inc., MilliporeSigma, Pall Corporation, Bio-Rad Laboratories, Charles River Laboratories International Inc., Waters Corporation, Becton Dickinson and Company (BD), Entegris Inc., Novasep, Avantor Sciences, Tecan Group, Agilent Technologies, Boehringer Ingelheim International GmbH, Ahlstrom-Munksjö Oyj, Grifols S.A., GenScript Biotech Corporation.

North America was the largest region in the downstream processing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global downstream processing market report during the forecast period. The regions covered in the downstream processing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the downstream processing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the downstream processing market by increasing costs of imported chromatography systems, filters, centrifuges, and single-use components. Biopharmaceutical manufacturers in North America and Europe are most affected due to dependence on specialized imported equipment. These tariffs increase production costs but encourage domestic equipment manufacturing and localized bioprocess supply chains.

The downstream processing market research report is one of a series of new reports that provides downstream processing market statistics, including downstream processing industry global market size, regional shares, competitors with a downstream processing market share, detailed downstream processing market segments, market trends and opportunities, and any further data you may need to thrive in the downstream processing industry. This downstream processing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Downstream processing refers to the recovery and purification of a drug substance (DS) from natural sources, such as animal or bacterial cells. It involves a series of steps required to produce a pure and homogeneous protein product from biological materials like cells, tissue culture fluid, or plant tissues.

The main products used in downstream processing include centrifuges, dryers, chromatography systems, filters, evaporators, and others, employing techniques such as purification, solid-liquid separation, and clarification or concentration. Centrifuges are devices that use centrifugal force to separate materials of different densities, remove moisture, or simulate the effects of gravity. Downstream processing is applied in multiple areas, including monoclonal antibody production, vaccine manufacturing, insulin production, immunoglobulin production, erythropoietin production, and others.

The downstream processing market consists of revenues earned by entities by providing downstream processing services such as cell separation, filtration, product recovery, extraction of products, and more. The market value includes the value of related goods sold by the service provider or included within the service offering. The Downstream processing market also includes sales of small-scale fermenters, pilot-scale fermenters, centrifuges, and membrane filtration systems which are used in providing downstream processing services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.